• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

¿Habla Español? | Clic Aqui

¿Habla

español?

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

80.98 USD UNCHANGED
Streaming Delayed Price Updated: 2:49 PM EST, Jan 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,317,460
Open 80.71
Bid (Size) 80.98 (17)
Ask (Size) 81.00 (6)
Prev. Close 80.98
Today's Range 80.06 - 81.19
52wk Range 65.25 - 89.20
Shares Outstanding 2,690,303,898
Dividend Yield 2.37%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Merck Canada and MaRS Team Up to Launch Lung Cancer Innovation Challenge
January 20, 2021
From PR Newswire
Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates; Continues Development of Two Investigational Therapeutic Candidates
Today 6:45 EST
Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates; Continues Development of Two Investigational Therapeutic Candidates 
From Business Wire News Releases

Performance

YTD
+0.02%
+0.02%
1 Month
+0.66%
+0.66%
3 Month
+2.71%
+2.71%
6 Month
+2.60%
+2.60%
1 Year
-5.95%
-5.95%

More News

Read More
ROCE Insights For Merck & Co
Today 9:45 EST
Tags Earnings MRK BZI/ROCE
From Benzinga
Biden to reinstate travel bans amid fears about new variants as global case tally heads toward 100 million
Today 11:06 EST
Tags Medical Products MRK Health/Care
From MarketWatch
Thinking about trading options or stock in Niu Technologies, Regeneron Pharmaceuticals, General Electric, Merck, or Axon Enterprise?
Today 9:31 EST
From PR Newswire
Merck Drops COVID-19 Vaccine Studies After Phase 1 Data Churn Out Inferior Efficacy Results
Today 8:01 EST
Tags Coronavirus News General
From Benzinga
Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat)
January 20, 2021
From Business Wire News Releases
Merck Scraps Development Of 'Inferior' Covid Vaccines; Shares Dip
Today 9:51 EST
From Investor's Business Daily
Implied FTXH Analyst Target Price: $30
Today 7:47 EST
Tags ETFs
From ETF Channel
Merck Ends Work On COVID-19 Vaccines, Still Working On Therapeutic Candidates
Today 8:36 EST
Tags Healthcare Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
Dow Jones Today, Futures Mixed As Merck Exits Covid Vaccine Race; Apple, Microsoft, AMD Rise Ahead Of Earnings
Today 8:18 EST
From Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap